NCT03112590
- Conditions
- Breast Cancer, Breast Cancer Female, Breast Cancer, Male, +8 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Breast Neoplasms, Male
Explore clinical trials studying Breast Neoplasms, Male. Study availability and eligibility vary by location and protocol.
213 public trials
6 recruiting studies
Breast Neoplasms, Male trial results
NCT00625417
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT02013492
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +42 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT00377156
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Cancer, +35 more
- Locations
-
- Arizona Oncology-Deer Valley Center Phoenix, Arizona, United States
- Arizona Oncology Services Foundation Scottsdale, Arizona, United States
- Memorial Medical Center Modesto, California, United States
- Kaiser Permanente - Division of Research - Oakland Oakland, California, United States
Completed
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
NCT03394027
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +22 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT00436566
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Mayo Clinic Cancer Research Consortium Rochester, Minnesota, United States
NCT00468715
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Completed
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer
NCT02586675
- Conditions
- Breast Cancer, Breast Cancer - Female, Breast Cancer - Male, +11 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00089323
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
- CCOP - Christiana Care Health Services Newark, Delaware, United States
- Morton Plant Hospital Clearwater, Florida, United States
Completed
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
NCT01009918
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- Todd Cancer Institute at Long Beach Memorial Medical Center Long Beach, California, United States
- Olive View - UCLA Medical Center Foundation Sylmar, California, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States